Plasma, subcutaneous tissue and bone concentrations of ceftiofur sodium after regional limb perfusion in horses.

This research examines how well an antibiotic drug, ceftiofur sodium, penetrates into the tissue and bone of horses’ limbs after treatment via Regional Limb Perfusion (RLP), a specialized local delivery method of medication.

Research Objective

The main objective of this study was to determine the concentrations of ceftiofur in the plasma, subcutaneous tissue (beneath the skin), and cortical bone in horses after undergoing RLP. The study attempted to understand whether the antibiotic adequately penetrates these three areas in order to effectively treat distal limb injuries and infections.

Methods Used

• Six healthy horses acted as the subjects of the study.
• A technique called Esmarch tourniquet was applied to each horse’s forelimbs under mild sedation.
• Each limb was injected with either ceftiofur sodium or saline, designated as the experimental or control limb respectively.
• The tourniquet ensured that the injected substance was concentrated in the limb for enhanced penetration and was removed 30 minutes after the injection.
• At 0.5, 12, and 24 hours post-injection, plasma, subcutaneous tissue, and cortical bone samples were collected from each horse.
• The samples were then tested to determine the concentrations of ceftiofur and its active metabolite, desfuroylceftiofur, using High Performance Liquid Chromatography-Tandem Mass Spectrometry (HPLC-MS).
• Finally, the concentration results from the experimental (ceftiofur-injected) limbs were compared to those from the control (saline-injected) limbs.

Results Analysis

• In both plasma and subcutaneous tissues, the concentration of ceftiofur retained was found to be above the minimum required to inhibit pathogen growth at first two time intervals examined.
• However, in the bone, this concentration was only found right after the tourniquet removal and not in subsequent time intervals.
• Therefore, while ceftiofur was successfully maintained in the plasma for up to 12 hours and in the subcutaneous tissue for 24 hours, its concentration in the bone was only satisfactory immediately after injection.

Conclusions and Further Research

While ceftiofur’s adequate penetration in plasma and subcutaneous tissues following RLP suggests it could be effective in treating distal limb infections, its suboptimal bone penetration calls for further research. This should focus on optimizing drug administration methods or finding alternative treatment options for bone infections. Additionally, disease states may affect the results, and as such, the implications of ceftiofur RLP therapy in such cases also warrant investigation.